nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—Hallucination, visual—Galantamine—Alzheimer's disease	0.0286	0.0453	CcSEcCtD
Scopolamine—SI—embryo—Alzheimer's disease	0.0251	0.163	CbGeAlD
Scopolamine—Application site burn—Rivastigmine—Alzheimer's disease	0.0245	0.0388	CcSEcCtD
Scopolamine—Hallucination, visual—Rivastigmine—Alzheimer's disease	0.0197	0.0312	CcSEcCtD
Scopolamine—Dental caries—Memantine—Alzheimer's disease	0.0141	0.0223	CcSEcCtD
Scopolamine—Dental caries—Rivastigmine—Alzheimer's disease	0.0138	0.0218	CcSEcCtD
Scopolamine—SI—nervous system—Alzheimer's disease	0.0121	0.0781	CbGeAlD
Scopolamine—Skin irritation—Rivastigmine—Alzheimer's disease	0.0119	0.0188	CcSEcCtD
Scopolamine—Application site pain—Rivastigmine—Alzheimer's disease	0.0117	0.0185	CcSEcCtD
Scopolamine—SI—central nervous system—Alzheimer's disease	0.0116	0.0752	CbGeAlD
Scopolamine—Paranoia—Galantamine—Alzheimer's disease	0.011	0.0173	CcSEcCtD
Scopolamine—SI—brain—Alzheimer's disease	0.00921	0.0597	CbGeAlD
Scopolamine—Paranoia—Donepezil—Alzheimer's disease	0.00849	0.0134	CcSEcCtD
Scopolamine—Paranoia—Memantine—Alzheimer's disease	0.00771	0.0122	CcSEcCtD
Scopolamine—Paranoia—Rivastigmine—Alzheimer's disease	0.00754	0.0119	CcSEcCtD
Scopolamine—Speech disorder—Memantine—Alzheimer's disease	0.00611	0.00967	CcSEcCtD
Scopolamine—Disturbance in attention—Memantine—Alzheimer's disease	0.00606	0.0096	CcSEcCtD
Scopolamine—Speech disorder—Rivastigmine—Alzheimer's disease	0.00597	0.00946	CcSEcCtD
Scopolamine—CHRM4—nervous system—Alzheimer's disease	0.00595	0.0386	CbGeAlD
Scopolamine—Disturbance in attention—Rivastigmine—Alzheimer's disease	0.00593	0.0094	CcSEcCtD
Scopolamine—CHRM2—forebrain—Alzheimer's disease	0.00588	0.0381	CbGeAlD
Scopolamine—CHRM4—central nervous system—Alzheimer's disease	0.00573	0.0371	CbGeAlD
Scopolamine—CHRM2—telencephalon—Alzheimer's disease	0.00541	0.0351	CbGeAlD
Scopolamine—CHRM1—forebrain—Alzheimer's disease	0.00536	0.0347	CbGeAlD
Scopolamine—Dry eye—Donepezil—Alzheimer's disease	0.00534	0.00846	CcSEcCtD
Scopolamine—Urinary retention—Galantamine—Alzheimer's disease	0.00515	0.00816	CcSEcCtD
Scopolamine—Depressed level of consciousness—Memantine—Alzheimer's disease	0.00507	0.00803	CcSEcCtD
Scopolamine—CHRM1—telencephalon—Alzheimer's disease	0.00492	0.0319	CbGeAlD
Scopolamine—CHRM3—forebrain—Alzheimer's disease	0.00479	0.0311	CbGeAlD
Scopolamine—Muscular weakness—Galantamine—Alzheimer's disease	0.00478	0.00757	CcSEcCtD
Scopolamine—Dysphagia—Galantamine—Alzheimer's disease	0.00468	0.00742	CcSEcCtD
Scopolamine—Eczema—Donepezil—Alzheimer's disease	0.00467	0.0074	CcSEcCtD
Scopolamine—CHRM5—nervous system—Alzheimer's disease	0.00465	0.0301	CbGeAlD
Scopolamine—CHRM4—brain—Alzheimer's disease	0.00455	0.0295	CbGeAlD
Scopolamine—CHRM5—central nervous system—Alzheimer's disease	0.00448	0.029	CbGeAlD
Scopolamine—Thirst—Donepezil—Alzheimer's disease	0.00441	0.00699	CcSEcCtD
Scopolamine—CHRM3—telencephalon—Alzheimer's disease	0.00441	0.0286	CbGeAlD
Scopolamine—Disorientation—Memantine—Alzheimer's disease	0.00426	0.00675	CcSEcCtD
Scopolamine—Eczema—Memantine—Alzheimer's disease	0.00424	0.00672	CcSEcCtD
Scopolamine—Eczema—Rivastigmine—Alzheimer's disease	0.00415	0.00657	CcSEcCtD
Scopolamine—Psychotic disorder—Donepezil—Alzheimer's disease	0.0041	0.0065	CcSEcCtD
Scopolamine—Amnesia—Memantine—Alzheimer's disease	0.00406	0.00643	CcSEcCtD
Scopolamine—Irritability—Donepezil—Alzheimer's disease	0.00401	0.00635	CcSEcCtD
Scopolamine—Urinary retention—Donepezil—Alzheimer's disease	0.00399	0.00632	CcSEcCtD
Scopolamine—Amnesia—Rivastigmine—Alzheimer's disease	0.00397	0.00629	CcSEcCtD
Scopolamine—Thirst—Rivastigmine—Alzheimer's disease	0.00392	0.00621	CcSEcCtD
Scopolamine—Dry skin—Donepezil—Alzheimer's disease	0.00385	0.0061	CcSEcCtD
Scopolamine—Bradycardia—Galantamine—Alzheimer's disease	0.00382	0.00604	CcSEcCtD
Scopolamine—Hallucination—Galantamine—Alzheimer's disease	0.00373	0.00591	CcSEcCtD
Scopolamine—Psychotic disorder—Memantine—Alzheimer's disease	0.00372	0.0059	CcSEcCtD
Scopolamine—Muscular weakness—Donepezil—Alzheimer's disease	0.0037	0.00587	CcSEcCtD
Scopolamine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.0037	0.00586	CcSEcCtD
Scopolamine—Urethral disorder—Galantamine—Alzheimer's disease	0.00367	0.00582	CcSEcCtD
Scopolamine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00364	0.00577	CcSEcCtD
Scopolamine—Irritability—Memantine—Alzheimer's disease	0.00364	0.00576	CcSEcCtD
Scopolamine—Dysphagia—Donepezil—Alzheimer's disease	0.00363	0.00575	CcSEcCtD
Scopolamine—Urinary retention—Memantine—Alzheimer's disease	0.00363	0.00574	CcSEcCtD
Scopolamine—Visual impairment—Galantamine—Alzheimer's disease	0.00361	0.00572	CcSEcCtD
Scopolamine—CHRM5—brain—Alzheimer's disease	0.00356	0.023	CbGeAlD
Scopolamine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00355	0.00562	CcSEcCtD
Scopolamine—ABCB1—blood vessel—Alzheimer's disease	0.00353	0.0229	CbGeAlD
Scopolamine—Eye disorder—Galantamine—Alzheimer's disease	0.0035	0.00555	CcSEcCtD
Scopolamine—Dry skin—Memantine—Alzheimer's disease	0.00349	0.00554	CcSEcCtD
Scopolamine—Flushing—Galantamine—Alzheimer's disease	0.00348	0.00551	CcSEcCtD
Scopolamine—Dry skin—Rivastigmine—Alzheimer's disease	0.00342	0.00542	CcSEcCtD
Scopolamine—Dysuria—Donepezil—Alzheimer's disease	0.00339	0.00538	CcSEcCtD
Scopolamine—Muscular weakness—Memantine—Alzheimer's disease	0.00336	0.00533	CcSEcCtD
Scopolamine—Arrhythmia—Galantamine—Alzheimer's disease	0.00335	0.0053	CcSEcCtD
Scopolamine—Dysphagia—Memantine—Alzheimer's disease	0.0033	0.00522	CcSEcCtD
Scopolamine—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00329	0.00521	CcSEcCtD
Scopolamine—Mental disorder—Galantamine—Alzheimer's disease	0.00328	0.0052	CcSEcCtD
Scopolamine—Dysphagia—Rivastigmine—Alzheimer's disease	0.00322	0.00511	CcSEcCtD
Scopolamine—CHRM2—nervous system—Alzheimer's disease	0.00319	0.0207	CbGeAlD
Scopolamine—Conjunctivitis—Donepezil—Alzheimer's disease	0.00315	0.00498	CcSEcCtD
Scopolamine—Sweating—Donepezil—Alzheimer's disease	0.0031	0.00491	CcSEcCtD
Scopolamine—Dysuria—Memantine—Alzheimer's disease	0.00308	0.00488	CcSEcCtD
Scopolamine—CHRM2—central nervous system—Alzheimer's disease	0.00308	0.0199	CbGeAlD
Scopolamine—Vision blurred—Galantamine—Alzheimer's disease	0.00308	0.00487	CcSEcCtD
Scopolamine—Tremor—Galantamine—Alzheimer's disease	0.00306	0.00484	CcSEcCtD
Scopolamine—Dysuria—Rivastigmine—Alzheimer's disease	0.00301	0.00478	CcSEcCtD
Scopolamine—Agitation—Galantamine—Alzheimer's disease	0.003	0.00475	CcSEcCtD
Scopolamine—Bradycardia—Donepezil—Alzheimer's disease	0.00296	0.00468	CcSEcCtD
Scopolamine—Vertigo—Galantamine—Alzheimer's disease	0.00293	0.00464	CcSEcCtD
Scopolamine—CHRM1—nervous system—Alzheimer's disease	0.00291	0.0188	CbGeAlD
Scopolamine—Hallucination—Donepezil—Alzheimer's disease	0.00289	0.00458	CcSEcCtD
Scopolamine—Pharyngitis—Donepezil—Alzheimer's disease	0.00288	0.00457	CcSEcCtD
Scopolamine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00287	0.00455	CcSEcCtD
Scopolamine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00287	0.00454	CcSEcCtD
Scopolamine—Conjunctivitis—Memantine—Alzheimer's disease	0.00286	0.00452	CcSEcCtD
Scopolamine—Urethral disorder—Donepezil—Alzheimer's disease	0.00285	0.00451	CcSEcCtD
Scopolamine—Visual impairment—Donepezil—Alzheimer's disease	0.0028	0.00443	CcSEcCtD
Scopolamine—CHRM1—central nervous system—Alzheimer's disease	0.0028	0.0181	CbGeAlD
Scopolamine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00279	0.00443	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00276	0.00437	CcSEcCtD
Scopolamine—Sweating—Rivastigmine—Alzheimer's disease	0.00276	0.00436	CcSEcCtD
Scopolamine—Dry mouth—Galantamine—Alzheimer's disease	0.00272	0.0043	CcSEcCtD
Scopolamine—Confusional state—Galantamine—Alzheimer's disease	0.00269	0.00425	CcSEcCtD
Scopolamine—Bradycardia—Memantine—Alzheimer's disease	0.00269	0.00425	CcSEcCtD
Scopolamine—Bradycardia—Rivastigmine—Alzheimer's disease	0.00263	0.00416	CcSEcCtD
Scopolamine—Hallucination—Memantine—Alzheimer's disease	0.00262	0.00416	CcSEcCtD
Scopolamine—Pharyngitis—Memantine—Alzheimer's disease	0.00262	0.00415	CcSEcCtD
Scopolamine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00261	0.00414	CcSEcCtD
Scopolamine—Urinary tract disorder—Memantine—Alzheimer's disease	0.0026	0.00413	CcSEcCtD
Scopolamine—CHRM3—nervous system—Alzheimer's disease	0.0026	0.0169	CbGeAlD
Scopolamine—Tachycardia—Galantamine—Alzheimer's disease	0.0026	0.00412	CcSEcCtD
Scopolamine—Arrhythmia—Donepezil—Alzheimer's disease	0.0026	0.00411	CcSEcCtD
Scopolamine—Skin disorder—Galantamine—Alzheimer's disease	0.00259	0.0041	CcSEcCtD
Scopolamine—Urethral disorder—Memantine—Alzheimer's disease	0.00259	0.0041	CcSEcCtD
Scopolamine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00257	0.00408	CcSEcCtD
Scopolamine—Hallucination—Rivastigmine—Alzheimer's disease	0.00257	0.00407	CcSEcCtD
Scopolamine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00256	0.00406	CcSEcCtD
Scopolamine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00255	0.00404	CcSEcCtD
Scopolamine—Mental disorder—Donepezil—Alzheimer's disease	0.00254	0.00403	CcSEcCtD
Scopolamine—Visual impairment—Memantine—Alzheimer's disease	0.00254	0.00403	CcSEcCtD
Scopolamine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00253	0.00401	CcSEcCtD
Scopolamine—Erythema—Donepezil—Alzheimer's disease	0.00253	0.00401	CcSEcCtD
Scopolamine—CHRM3—central nervous system—Alzheimer's disease	0.00251	0.0162	CbGeAlD
Scopolamine—Hypotension—Galantamine—Alzheimer's disease	0.00249	0.00394	CcSEcCtD
Scopolamine—Visual impairment—Rivastigmine—Alzheimer's disease	0.00249	0.00394	CcSEcCtD
Scopolamine—Eye disorder—Memantine—Alzheimer's disease	0.00246	0.0039	CcSEcCtD
Scopolamine—Flushing—Memantine—Alzheimer's disease	0.00245	0.00388	CcSEcCtD
Scopolamine—CHRM2—brain—Alzheimer's disease	0.00244	0.0158	CbGeAlD
Scopolamine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00241	0.00382	CcSEcCtD
Scopolamine—Flushing—Rivastigmine—Alzheimer's disease	0.00239	0.00379	CcSEcCtD
Scopolamine—Vision blurred—Donepezil—Alzheimer's disease	0.00238	0.00378	CcSEcCtD
Scopolamine—Tremor—Donepezil—Alzheimer's disease	0.00237	0.00375	CcSEcCtD
Scopolamine—Somnolence—Galantamine—Alzheimer's disease	0.00237	0.00375	CcSEcCtD
Scopolamine—Arrhythmia—Memantine—Alzheimer's disease	0.00236	0.00373	CcSEcCtD
Scopolamine—Agitation—Donepezil—Alzheimer's disease	0.00232	0.00368	CcSEcCtD
Scopolamine—Mental disorder—Memantine—Alzheimer's disease	0.00231	0.00366	CcSEcCtD
Scopolamine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00231	0.00365	CcSEcCtD
Scopolamine—Fatigue—Galantamine—Alzheimer's disease	0.0023	0.00364	CcSEcCtD
Scopolamine—Constipation—Galantamine—Alzheimer's disease	0.00228	0.00361	CcSEcCtD
Scopolamine—Vertigo—Donepezil—Alzheimer's disease	0.00227	0.0036	CcSEcCtD
Scopolamine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00226	0.00358	CcSEcCtD
Scopolamine—Erythema—Rivastigmine—Alzheimer's disease	0.00225	0.00356	CcSEcCtD
Scopolamine—CHRM1—brain—Alzheimer's disease	0.00222	0.0144	CbGeAlD
Scopolamine—Feeling abnormal—Galantamine—Alzheimer's disease	0.00219	0.00348	CcSEcCtD
Scopolamine—Vision blurred—Memantine—Alzheimer's disease	0.00216	0.00343	CcSEcCtD
Scopolamine—Tremor—Memantine—Alzheimer's disease	0.00215	0.00341	CcSEcCtD
Scopolamine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00212	0.00335	CcSEcCtD
Scopolamine—Agitation—Memantine—Alzheimer's disease	0.00211	0.00334	CcSEcCtD
Scopolamine—ABCB1—embryo—Alzheimer's disease	0.00211	0.0137	CbGeAlD
Scopolamine—Dry mouth—Donepezil—Alzheimer's disease	0.00211	0.00334	CcSEcCtD
Scopolamine—Body temperature increased—Galantamine—Alzheimer's disease	0.00211	0.00333	CcSEcCtD
Scopolamine—Abdominal pain—Galantamine—Alzheimer's disease	0.00211	0.00333	CcSEcCtD
Scopolamine—Tremor—Rivastigmine—Alzheimer's disease	0.0021	0.00333	CcSEcCtD
Scopolamine—Confusional state—Donepezil—Alzheimer's disease	0.00208	0.0033	CcSEcCtD
Scopolamine—Agitation—Rivastigmine—Alzheimer's disease	0.00206	0.00327	CcSEcCtD
Scopolamine—Oedema—Donepezil—Alzheimer's disease	0.00206	0.00327	CcSEcCtD
Scopolamine—Vertigo—Memantine—Alzheimer's disease	0.00206	0.00327	CcSEcCtD
Scopolamine—Nervous system disorder—Donepezil—Alzheimer's disease	0.00202	0.00321	CcSEcCtD
Scopolamine—Vertigo—Rivastigmine—Alzheimer's disease	0.00202	0.0032	CcSEcCtD
Scopolamine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.002	0.00316	CcSEcCtD
Scopolamine—CHRM3—brain—Alzheimer's disease	0.00199	0.0129	CbGeAlD
Scopolamine—Hypotension—Donepezil—Alzheimer's disease	0.00193	0.00305	CcSEcCtD
Scopolamine—Dry mouth—Memantine—Alzheimer's disease	0.00191	0.00303	CcSEcCtD
Scopolamine—Asthenia—Galantamine—Alzheimer's disease	0.00191	0.00303	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.0019	0.00301	CcSEcCtD
Scopolamine—Confusional state—Memantine—Alzheimer's disease	0.00189	0.00299	CcSEcCtD
Scopolamine—Oedema—Memantine—Alzheimer's disease	0.00187	0.00297	CcSEcCtD
Scopolamine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00187	0.00296	CcSEcCtD
Scopolamine—ABCB1—forebrain—Alzheimer's disease	0.00186	0.0121	CbGeAlD
Scopolamine—Confusional state—Rivastigmine—Alzheimer's disease	0.00185	0.00293	CcSEcCtD
Scopolamine—Nervous system disorder—Memantine—Alzheimer's disease	0.00184	0.00291	CcSEcCtD
Scopolamine—Somnolence—Donepezil—Alzheimer's disease	0.00183	0.00291	CcSEcCtD
Scopolamine—Oedema—Rivastigmine—Alzheimer's disease	0.00183	0.0029	CcSEcCtD
Scopolamine—Tachycardia—Memantine—Alzheimer's disease	0.00183	0.0029	CcSEcCtD
Scopolamine—Skin disorder—Memantine—Alzheimer's disease	0.00182	0.00288	CcSEcCtD
Scopolamine—Hyperhidrosis—Memantine—Alzheimer's disease	0.00181	0.00287	CcSEcCtD
Scopolamine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.0018	0.00285	CcSEcCtD
Scopolamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00179	0.00283	CcSEcCtD
Scopolamine—Skin disorder—Rivastigmine—Alzheimer's disease	0.00178	0.00282	CcSEcCtD
Scopolamine—Fatigue—Donepezil—Alzheimer's disease	0.00178	0.00282	CcSEcCtD
Scopolamine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00177	0.00281	CcSEcCtD
Scopolamine—Pain—Donepezil—Alzheimer's disease	0.00176	0.0028	CcSEcCtD
Scopolamine—Constipation—Donepezil—Alzheimer's disease	0.00176	0.0028	CcSEcCtD
Scopolamine—Dizziness—Galantamine—Alzheimer's disease	0.00176	0.00279	CcSEcCtD
Scopolamine—Hypotension—Memantine—Alzheimer's disease	0.00175	0.00277	CcSEcCtD
Scopolamine—ABCB1—telencephalon—Alzheimer's disease	0.00171	0.0111	CbGeAlD
Scopolamine—Hypotension—Rivastigmine—Alzheimer's disease	0.00171	0.00271	CcSEcCtD
Scopolamine—Feeling abnormal—Donepezil—Alzheimer's disease	0.0017	0.00269	CcSEcCtD
Scopolamine—Vomiting—Galantamine—Alzheimer's disease	0.00169	0.00268	CcSEcCtD
Scopolamine—Rash—Galantamine—Alzheimer's disease	0.00168	0.00266	CcSEcCtD
Scopolamine—Dermatitis—Galantamine—Alzheimer's disease	0.00168	0.00266	CcSEcCtD
Scopolamine—Headache—Galantamine—Alzheimer's disease	0.00167	0.00264	CcSEcCtD
Scopolamine—Somnolence—Memantine—Alzheimer's disease	0.00167	0.00264	CcSEcCtD
Scopolamine—Abdominal pain—Donepezil—Alzheimer's disease	0.00163	0.00258	CcSEcCtD
Scopolamine—Body temperature increased—Donepezil—Alzheimer's disease	0.00163	0.00258	CcSEcCtD
Scopolamine—Somnolence—Rivastigmine—Alzheimer's disease	0.00163	0.00258	CcSEcCtD
Scopolamine—Fatigue—Memantine—Alzheimer's disease	0.00162	0.00256	CcSEcCtD
Scopolamine—Pain—Memantine—Alzheimer's disease	0.0016	0.00254	CcSEcCtD
Scopolamine—Constipation—Memantine—Alzheimer's disease	0.0016	0.00254	CcSEcCtD
Scopolamine—Nausea—Galantamine—Alzheimer's disease	0.00158	0.00251	CcSEcCtD
Scopolamine—Fatigue—Rivastigmine—Alzheimer's disease	0.00158	0.0025	CcSEcCtD
Scopolamine—Pain—Rivastigmine—Alzheimer's disease	0.00157	0.00248	CcSEcCtD
Scopolamine—Constipation—Rivastigmine—Alzheimer's disease	0.00157	0.00248	CcSEcCtD
Scopolamine—Feeling abnormal—Memantine—Alzheimer's disease	0.00154	0.00245	CcSEcCtD
Scopolamine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00151	0.00239	CcSEcCtD
Scopolamine—Abdominal pain—Memantine—Alzheimer's disease	0.00148	0.00235	CcSEcCtD
Scopolamine—Body temperature increased—Memantine—Alzheimer's disease	0.00148	0.00235	CcSEcCtD
Scopolamine—Asthenia—Donepezil—Alzheimer's disease	0.00148	0.00235	CcSEcCtD
Scopolamine—Pruritus—Donepezil—Alzheimer's disease	0.00146	0.00231	CcSEcCtD
Scopolamine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00145	0.0023	CcSEcCtD
Scopolamine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00145	0.0023	CcSEcCtD
Scopolamine—Dizziness—Donepezil—Alzheimer's disease	0.00136	0.00216	CcSEcCtD
Scopolamine—Asthenia—Memantine—Alzheimer's disease	0.00134	0.00213	CcSEcCtD
Scopolamine—Pruritus—Memantine—Alzheimer's disease	0.00133	0.0021	CcSEcCtD
Scopolamine—Asthenia—Rivastigmine—Alzheimer's disease	0.00132	0.00208	CcSEcCtD
Scopolamine—Vomiting—Donepezil—Alzheimer's disease	0.00131	0.00208	CcSEcCtD
Scopolamine—Rash—Donepezil—Alzheimer's disease	0.0013	0.00206	CcSEcCtD
Scopolamine—Dermatitis—Donepezil—Alzheimer's disease	0.0013	0.00206	CcSEcCtD
Scopolamine—Pruritus—Rivastigmine—Alzheimer's disease	0.0013	0.00205	CcSEcCtD
Scopolamine—Headache—Donepezil—Alzheimer's disease	0.00129	0.00205	CcSEcCtD
Scopolamine—Dizziness—Memantine—Alzheimer's disease	0.00124	0.00196	CcSEcCtD
Scopolamine—Nausea—Donepezil—Alzheimer's disease	0.00123	0.00194	CcSEcCtD
Scopolamine—Dizziness—Rivastigmine—Alzheimer's disease	0.00121	0.00192	CcSEcCtD
Scopolamine—Vomiting—Memantine—Alzheimer's disease	0.00119	0.00189	CcSEcCtD
Scopolamine—Rash—Memantine—Alzheimer's disease	0.00118	0.00187	CcSEcCtD
Scopolamine—Dermatitis—Memantine—Alzheimer's disease	0.00118	0.00187	CcSEcCtD
Scopolamine—Headache—Memantine—Alzheimer's disease	0.00117	0.00186	CcSEcCtD
Scopolamine—Vomiting—Rivastigmine—Alzheimer's disease	0.00117	0.00185	CcSEcCtD
Scopolamine—Rash—Rivastigmine—Alzheimer's disease	0.00116	0.00183	CcSEcCtD
Scopolamine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00115	0.00183	CcSEcCtD
Scopolamine—Headache—Rivastigmine—Alzheimer's disease	0.00115	0.00182	CcSEcCtD
Scopolamine—Nausea—Memantine—Alzheimer's disease	0.00111	0.00176	CcSEcCtD
Scopolamine—Nausea—Rivastigmine—Alzheimer's disease	0.00109	0.00172	CcSEcCtD
Scopolamine—ABCB1—nervous system—Alzheimer's disease	0.00101	0.00656	CbGeAlD
Scopolamine—ABCB1—central nervous system—Alzheimer's disease	0.000974	0.00631	CbGeAlD
Scopolamine—ABCB1—cerebellum—Alzheimer's disease	0.000952	0.00617	CbGeAlD
Scopolamine—ABCB1—brain—Alzheimer's disease	0.000774	0.00501	CbGeAlD
Scopolamine—ABCB1—Metabolism—CHAT—Alzheimer's disease	5.59e-05	0.000261	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	5.59e-05	0.000261	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	5.57e-05	0.00026	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1R—Alzheimer's disease	5.55e-05	0.000259	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	5.52e-05	0.000258	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF2—Alzheimer's disease	5.49e-05	0.000256	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	5.47e-05	0.000255	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	5.46e-05	0.000254	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ABCA1—Alzheimer's disease	5.45e-05	0.000254	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	5.4e-05	0.000252	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	5.37e-05	0.000251	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MAOB—Alzheimer's disease	5.36e-05	0.00025	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	5.36e-05	0.00025	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	5.35e-05	0.000249	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	5.33e-05	0.000249	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—LPL—Alzheimer's disease	5.32e-05	0.000248	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1R—Alzheimer's disease	5.31e-05	0.000248	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	5.3e-05	0.000247	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	5.28e-05	0.000246	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	5.28e-05	0.000246	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MEF2C—Alzheimer's disease	5.27e-05	0.000246	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	5.27e-05	0.000246	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	5.27e-05	0.000246	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	5.25e-05	0.000245	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	5.22e-05	0.000243	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	5.2e-05	0.000243	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PRKCG—Alzheimer's disease	5.17e-05	0.000241	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GAPDH—Alzheimer's disease	5.16e-05	0.000241	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SST—Alzheimer's disease	5.13e-05	0.000239	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	5.13e-05	0.000239	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	5.13e-05	0.000239	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SST—Alzheimer's disease	5.11e-05	0.000238	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	5.11e-05	0.000238	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	5.11e-05	0.000238	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	5.11e-05	0.000238	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—LPL—Alzheimer's disease	5.09e-05	0.000238	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	5.09e-05	0.000237	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	5.08e-05	0.000237	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	5.07e-05	0.000236	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	5.06e-05	0.000236	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SST—Alzheimer's disease	5.06e-05	0.000236	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	5.06e-05	0.000236	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MEF2C—Alzheimer's disease	5.05e-05	0.000235	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	5.04e-05	0.000235	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NGF—Alzheimer's disease	5.04e-05	0.000235	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	5.02e-05	0.000234	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APP—Alzheimer's disease	5e-05	0.000233	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—A2M—Alzheimer's disease	4.99e-05	0.000233	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	4.99e-05	0.000233	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APP—Alzheimer's disease	4.98e-05	0.000232	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PRKCG—Alzheimer's disease	4.95e-05	0.000231	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	4.93e-05	0.00023	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCR5—Alzheimer's disease	4.9e-05	0.000229	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NGF—Alzheimer's disease	4.82e-05	0.000225	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	4.8e-05	0.000224	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR2A—Alzheimer's disease	4.79e-05	0.000224	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	4.78e-05	0.000223	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	4.74e-05	0.000221	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	4.71e-05	0.00022	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	4.7e-05	0.000219	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	4.69e-05	0.000219	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCR5—Alzheimer's disease	4.69e-05	0.000219	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—HMOX1—Alzheimer's disease	4.67e-05	0.000218	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	4.65e-05	0.000217	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR2A—Alzheimer's disease	4.59e-05	0.000214	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CALM1—Alzheimer's disease	4.47e-05	0.000209	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOE—Alzheimer's disease	4.46e-05	0.000208	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—LEP—Alzheimer's disease	4.46e-05	0.000208	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CAV1—Alzheimer's disease	4.42e-05	0.000206	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	4.4e-05	0.000205	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	4.38e-05	0.000205	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	4.37e-05	0.000204	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	4.36e-05	0.000203	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	4.34e-05	0.000203	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ACHE—Alzheimer's disease	4.34e-05	0.000202	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	4.31e-05	0.000201	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	4.3e-05	0.0002	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	4.29e-05	0.0002	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CALM1—Alzheimer's disease	4.28e-05	0.0002	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	4.28e-05	0.0002	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	4.28e-05	0.0002	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—LPL—Alzheimer's disease	4.27e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—LEP—Alzheimer's disease	4.27e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOE—Alzheimer's disease	4.27e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	4.26e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ESR1—Alzheimer's disease	4.26e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	4.24e-05	0.000198	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CAV1—Alzheimer's disease	4.23e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	4.22e-05	0.000197	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.21e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—F2—Alzheimer's disease	4.2e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOTCH1—Alzheimer's disease	4.11e-05	0.000192	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ESR1—Alzheimer's disease	4.08e-05	0.00019	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	4.06e-05	0.00019	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ENO1—Alzheimer's disease	4.06e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	4.06e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	4.05e-05	0.000189	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—F2—Alzheimer's disease	4.03e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	4.01e-05	0.000187	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	3.99e-05	0.000186	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	3.94e-05	0.000184	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	3.87e-05	0.00018	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GSK3B—Alzheimer's disease	3.86e-05	0.00018	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	3.86e-05	0.00018	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTHFR—Alzheimer's disease	3.85e-05	0.00018	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CREB1—Alzheimer's disease	3.83e-05	0.000179	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	3.82e-05	0.000178	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—INS—Alzheimer's disease	3.81e-05	0.000178	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—BCHE—Alzheimer's disease	3.78e-05	0.000176	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL2—Alzheimer's disease	3.75e-05	0.000175	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	3.74e-05	0.000174	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	3.73e-05	0.000174	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GSK3B—Alzheimer's disease	3.7e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	3.69e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1—Alzheimer's disease	3.68e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CREB1—Alzheimer's disease	3.67e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—INS—Alzheimer's disease	3.65e-05	0.00017	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CALM1—Alzheimer's disease	3.6e-05	0.000168	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL2—Alzheimer's disease	3.59e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	3.59e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—Alzheimer's disease	3.58e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	3.57e-05	0.000167	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	3.57e-05	0.000166	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	3.55e-05	0.000166	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CAV1—Alzheimer's disease	3.55e-05	0.000166	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	3.54e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	3.54e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1—Alzheimer's disease	3.53e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	3.51e-05	0.000164	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	3.49e-05	0.000163	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	3.48e-05	0.000162	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.46e-05	0.000161	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	3.44e-05	0.000161	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	3.4e-05	0.000158	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	3.39e-05	0.000158	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	3.35e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOS3—Alzheimer's disease	3.34e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	3.3e-05	0.000154	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	3.29e-05	0.000154	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	3.26e-05	0.000152	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	3.23e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	3.22e-05	0.00015	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	3.2e-05	0.000149	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	3.19e-05	0.000149	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—Alzheimer's disease	3.12e-05	0.000146	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—INS—Alzheimer's disease	3.06e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	3.02e-05	0.000141	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	3.01e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	3.01e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	3.01e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	3e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	3e-05	0.00014	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.98e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	2.98e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	2.98e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	2.97e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	2.97e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	2.97e-05	0.000138	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.97e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	2.94e-05	0.000137	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	2.87e-05	0.000134	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—Alzheimer's disease	2.86e-05	0.000133	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	2.86e-05	0.000133	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CASP3—Alzheimer's disease	2.84e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	2.83e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	2.83e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—F2—Alzheimer's disease	2.83e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	2.82e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	2.8e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.77e-05	0.000129	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	2.76e-05	0.000129	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	2.74e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.74e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	2.71e-05	0.000127	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LPL—Alzheimer's disease	2.71e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	2.7e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NOS3—Alzheimer's disease	2.68e-05	0.000125	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	2.61e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.6e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	2.6e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	2.59e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.58e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	2.57e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	2.57e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	2.57e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	2.56e-05	0.000119	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	2.55e-05	0.000119	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	2.53e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	2.53e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	2.52e-05	0.000117	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	2.5e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.49e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	2.49e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.48e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	2.48e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	2.45e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.45e-05	0.000114	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.44e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	2.41e-05	0.000112	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	2.3e-05	0.000107	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.28e-05	0.000106	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—Alzheimer's disease	2.27e-05	0.000106	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.25e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.25e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	2.24e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	2.22e-05	0.000104	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	2.21e-05	0.000103	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	2.11e-05	9.86e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.98e-05	9.24e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—INS—Alzheimer's disease	1.94e-05	9.06e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.93e-05	9e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.92e-05	8.97e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.91e-05	8.92e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.91e-05	8.89e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.9e-05	8.89e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.9e-05	8.86e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.89e-05	8.83e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.89e-05	8.8e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.87e-05	8.75e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.82e-05	8.48e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.76e-05	8.2e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.75e-05	8.17e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.75e-05	8.17e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.75e-05	8.15e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.74e-05	8.12e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.73e-05	8.09e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.73e-05	8.07e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.7e-05	7.95e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.66e-05	7.76e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.62e-05	7.57e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.62e-05	7.54e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.6e-05	7.47e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.59e-05	7.43e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.56e-05	7.27e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.54e-05	7.16e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.49e-05	6.95e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.48e-05	6.92e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.47e-05	6.86e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.47e-05	6.86e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.23e-05	5.76e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.23e-05	5.72e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.22e-05	5.7e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.21e-05	5.64e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.12e-05	5.23e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.12e-05	5.22e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.11e-05	5.17e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.04e-05	4.83e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	1.03e-05	4.81e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.02e-05	4.77e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—Alzheimer's disease	7.83e-06	3.65e-05	CbGpPWpGaD
